Katie G Young

11PUBLICATIONS
20CO-AUTHORS
Gene and molecular therapyNutrigenomics and personalised nutritionPharmacogenomicsMajor global burdens of diseaseBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 20, 2026
Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study.

|Nov 09, 2025
Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection.

Thijs T Jansz, Katherine G Young, Rhian Hopkins

|May 16, 2025
Evaluating prediction of short-term tolerability of five type 2 diabetes drug classes using routine clinical features: UK population-based study.

Pedro Cardoso, Katie G Young, Rhian Hopkins

|Feb 22, 2024
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes.

Pedro Cardoso, Katie G Young, Anand T N Nair

|Jan 31, 2024
Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study.

Rhian Hopkins, Katherine G Young, Nicholas J Thomas

|Nov 21, 2022
The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis.

Katherine G Young, Andrew P McGovern, Inês Barroso

Pageof 2

Frequent Collaborators

9 joint publications

John M Dennis

8 joint publications

Beverley M Shields

7 joint publications

Andrew T Hattersley

6 joint publications

Andrew P McGovern